扒哥吃瓜

Cookies on 扒哥吃瓜

We use some essential cookies to make this website work.

We鈥檇 like to set additional cookies to understand how you use 扒哥吃瓜, remember your settings and improve government services.

We also use cookies set by other sites to help us deliver content from their services.

You have accepted additional cookies. You can change your cookie settings at any time.

You have rejected additional cookies. You can change your cookie settings at any time.

View cookies

Benefits
Births, death, marriages and care
Business and self-employed
Childcare and parenting
Citizenship and living in the UK
Crime, justice and the law
Disabled people
Driving and transport
Education and learning
Employing people
Environment and countryside
Housing and local services
Money and tax
Passports, travel and living abroad
Visas and immigration
Working, jobs and pensions

Government activity

Departments
Departments, agencies and public bodies
News
News stories, speeches, letters and notices
Guidance and regulation
Detailed guidance, regulations and rules
Research and statistics
Reports, analysis and official statistics
Policy papers and consultations
Consultations and strategy
Transparency
Data, Freedom of Information releases and corporate reports

Search 扒哥吃瓜

Search

Search 扒哥吃瓜

Home
Health and social care
Medicines, medical devices
Vigilance, safety alerts and guidance
Alerts and recalls

Drug Safety Update

From:: Medicines and Healthcare products Regulatory Agency

Alerts, recalls and safety information: medicines and medical devices

Search Drug Safety Update

Skip to results

Filter

62 updates

Therapeutic area

Anaesthesia and intensive care

Breastfeeding

Cancer

Cardiovascular disease and lipidology

Care home staff

Cosmetic surgery

Critical care

Dentistry

Dermatology

Dispensing GP practices

Ear, nose and throat

Emergency medicine

Endocrinology, diabetology and metabolism

General practice

General surgery

GI, hepatology and pancreatic disorders

Haematology and oncology

Immunology and vaccination

Immunosuppression and transplantation

Infection prevention

Infectious disease

Neurology

Nutrition and dietetics

Obstetrics, gynaecology and fertility

Ophthalmology

Orthopaedics

Paediatrics and neonatology

Pain management and palliation

Pathology

Pharmacy

Physiotherapy and occupational therapy

Pregnancy

Psychiatry

Radiology and imaging

Renal medicine

Respiratory disease and allergy

Rheumatology

Theatre practitioners

Urology and nephrology

Vascular and cardiac surgery

Published

Published after

For example, 2005 or 21/11/2014

Published before

For example, 2005 or 21/11/2014

62 updates

About Dispensing GP practices

Go to search results

62 updates

Skip to results

Subscribe to feed

62 updates

About Dispensing GP practices

COVID-19 vaccines and medicines: updates for March 2022

Recent information relating to COVID-19 vaccines and medicines that has been published since the February 2022 issue of Drug Safety Update, up to 11 March 2022
- Therapeutic area: Dispensing GP practices and 2 others
- Published: 15 March 2022
COVID-19 antivirals: reporting to the UK COVID-19 Antivirals Pregnancy Registry

As the safety of COVID-19 antivirals in pregnancy has not been established, please report any pregnancies which occur during use of an antiviral, including paternal use, to the UK COVID-19 Antivirals Pregnancy Registry. This鈥�
- Therapeutic area: Dispensing GP practices and 1 others
- Published: 15 February 2022
Hydroxychloroquine, chloroquine: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions

Carefully consider the benefits and risks before prescribing systemic azithromycin or other systemic macrolide antibiotics (erythromycin or clarithromycin) to patients being treated with hydroxychloroquine or chloroquine. An鈥�
- Therapeutic area: Dermatology and 3 others
- Published: 15 February 2022
COVID-19 vaccines and medicines: updates for February 2022

Recent information relating to COVID-19 vaccines and medicines that has been published since the January 2022 issue of Drug Safety Update, up to 11 February 2022.
- Therapeutic area: Dispensing GP practices and 2 others
- Published: 15 February 2022
Letters and medicine recalls sent to healthcare professionals in January 2022

A summary of recent letters, medicine recalls and notifications sent to healthcare professionals.
- Therapeutic area: Dispensing GP practices and 6 others
- Published: 15 February 2022
COVID-19 vaccines and medicines: updates for January 2022

Recent information relating to COVID-19 vaccines and medicines that has been published since the December 2021 issue of Drug Safety Update, up to 13 January 2022.
- Therapeutic area: Dispensing GP practices and 2 others
- Published: 18 January 2022
Letters and medicine recalls sent to healthcare professionals in December 2021

A summary of recent letters, medicine recalls and notifications sent to healthcare professionals.
- Therapeutic area: Cardiovascular disease and lipidology and 10 others
- Published: 18 January 2022
Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus

The authorisation holder for dapagliflozin has withdrawn the indication for type 1 diabetes mellitus. The removal of the type 1 diabetes indication is not due to any new safety concerns and the other indications of dapaglifl鈥�
- Therapeutic area: Dispensing GP practices and 1 others
- Published: 10 December 2021
COVID-19 vaccines and medicines: updates for December 2021

Recent information relating to COVID-19 vaccines and medicines that has been published since the November 2021 issue of Drug Safety Update, up to 3 December 2021.
- Therapeutic area: Dispensing GP practices and 2 others
- Published: 10 December 2021
Letters and medicine recalls sent to healthcare professionals in November 2021

A summary of recent letters, medicine recalls and notifications sent to healthcare professionals.
- Therapeutic area: Cancer and 13 others
- Published: 10 December 2021
Adrenaline auto-injectors: reminder for prescribers to support safe and effective use

Emerade 300 and 500 microgram adrenaline auto-injectors have been re-supplied to the market following the implementation of corrective actions 鈥� patients and their caregivers should be provided with training and advice speci鈥�
- Therapeutic area: Dispensing GP practices and 2 others
- Published: 16 November 2021
Letters and medicine recalls sent to healthcare professionals in October 2021

A summary of recent letters, medicine recalls and notifications sent to healthcare professionals.
- Therapeutic area: Cancer and 9 others
- Published: 16 November 2021

Previous page:1 of 2

Subscribe to feed

Is this page useful?

Thank you for your feedback

Help us improve 扒哥吃瓜

Do not include personal or financial information like your National Insurance number or credit card details.

This field is for robots only. Please leave blank

What were you doing?

What went wrong?

Help us improve 扒哥吃瓜

To help us improve 扒哥吃瓜, we鈥檇 like to know more about your visit today. .

Services and information

Benefits
Births, death, marriages and care
Business and self-employed
Childcare and parenting
Citizenship and living in the UK
Crime, justice and the law
Disabled people
Driving and transport
Education and learning
Employing people
Environment and countryside
Housing and local services
Money and tax
Passports, travel and living abroad
Visas and immigration
Working, jobs and pensions

Government activity

Departments
News
Guidance and regulation
Research and statistics
Policy papers and consultations
Transparency
How government works
Get involved

All content is available under the , except where otherwise stated